Patents by Inventor Sin Ying CHEUNG

Sin Ying CHEUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRPC ion channel inhibitors for use in therapy
    Patent number: 12053475
    Abstract: Described herein are inhibitors Transient Receptor Potential Canonical (TRPC) ion channels comprising TRPC4 protein and/or TRPC5 protein for use in combating obesity and other medical conditions including insulin resistance associated with Type II diabetes or development of Type II diabetes (pre-diabetes), metabolic syndrome, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Also disclosed is the use of the inhibitors for cosmetic purposes, such as cosmetic weight loss.
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: August 6, 2024
    Assignee: University of Leeds
    Inventors: David John Beech, Richard James Foster, Sin Ying Cheung, Baptiste Michel Rode
  • TRPC ION CHANNEL INHIBITORS FOR USE IN THERAPY
    Publication number: 20220031706
    Abstract: Described herein are inhibitors Transient Receptor Potential Canonical (TRPC) ion channels comprising TRPC4 protein and/or TRPC5 protein for use in combating obesity and other medical conditions including insulin resistance associated with Type II diabetes or development of Type II diabetes (pre-diabetes), metabolic syndrome, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Also disclosed is the use of the inhibitors for cosmetic purposes, such as cosmetic weight loss.
    Type: Application
    Filed: October 15, 2021
    Publication date: February 3, 2022
    Inventors: David John BEECH, Richard James FOSTER, Sin Ying CHEUNG, Baptiste Michel RODE
  • TRPC ION CHANNEL INHIBITORS FOR USE IN THERAPY
    Publication number: 20200345741
    Abstract: Described herein are inhibitors Transient Receptor Potential Canonical (TRPC) ion channels comprising TRPC4 protein and/or TRPC5 protein for use in combating obesity and other medical conditions including insulin resistance associated with Type II diabetes or development of Type II diabetes (pre-diabetes), metabolic syndrome, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Also disclosed is the use of the inhibitors for cosmetic purposes, such as cosmetic weight loss.
    Type: Application
    Filed: February 9, 2018
    Publication date: November 5, 2020
    Inventors: David John BEECH, Richard James FOSTER, Sin Ying CHEUNG, Baptiste Michel RODE